This Article Full Text (OnlineFirst PDF) All Versions of this Article: 0897190008322151v1 22/1/6    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Krypel, L. K. Search for Related Content Social Bookmarking                         What's this?

Fibromyalgia: A Review of Its Pathophysiology and Drug Treatment

^* To whom correspondence should be addressed. E-mail: linda.krypel{at}drake.edu.

	Abstract

The objective of this article is to review the literature related to the pathophysiology of fibromyalgia and the drug therapy used to treat this disease. Fibromyalgia, the second most frequently diagnosed rheumatological disorder, has complex interrelated pathologies that must be addressed to achieve effective symptom control. Central and peripheral sensitization along with neurotransmitter abnormalities play a major role in defining the symptoms associated with this disease. Drug therapy must be multifaceted because no single drug addresses all pathologies. Drug and nondrug therapies showing strong-to-moderate effectiveness should be used to obtain the most benefit.

First published on September 9, 2008, doi:10.1177/0897190008322151

Journal of Pharmacy Practice 2009;22:6.

A more recent version of this article appeared on February 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?